Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB - US7194051022 - Common Stock

22.07 USD
-0.01 (-0.05%)
Last: 8/25/2025, 8:00:01 PM
22.07 USD
0 (0%)
After Hours: 8/25/2025, 8:00:01 PM
Fundamental Rating

6

Overall PLAB gets a fundamental rating of 6 out of 10. We evaluated PLAB against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB gets an excellent profitability rating and is at the same time showing great financial health properties. PLAB may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make PLAB a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
In the past year PLAB had a positive cash flow from operations.
Each year in the past 5 years PLAB has been profitable.
Each year in the past 5 years PLAB had a positive operating cash flow.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

PLAB has a better Return On Assets (7.04%) than 73.64% of its industry peers.
The Return On Equity of PLAB (10.90%) is better than 75.45% of its industry peers.
PLAB's Return On Invested Capital of 10.42% is amongst the best of the industry. PLAB outperforms 80.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PLAB is in line with the industry average of 10.98%.
Industry RankSector Rank
ROA 7.04%
ROE 10.9%
ROIC 10.42%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

The Profit Margin of PLAB (14.00%) is better than 73.64% of its industry peers.
In the last couple of years the Profit Margin of PLAB has grown nicely.
PLAB has a Operating Margin of 25.20%. This is amongst the best in the industry. PLAB outperforms 83.64% of its industry peers.
In the last couple of years the Operating Margin of PLAB has grown nicely.
PLAB has a worse Gross Margin (36.29%) than 64.55% of its industry peers.
In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 25.2%
PM (TTM) 14%
GM 36.29%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PLAB is still creating some value.
PLAB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PLAB has been reduced compared to 5 years ago.
PLAB has a better debt/assets ratio than last year.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

PLAB has an Altman-Z score of 3.30. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.30, PLAB perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
The Debt to FCF ratio of PLAB is 0.00, which is an excellent value as it means it would take PLAB, only 0.00 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PLAB (0.00) is better than 85.45% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
The Debt to Equity ratio of PLAB (0.00) is better than 70.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.3
ROIC/WACC0.89
WACC11.66%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

PLAB has a Current Ratio of 5.13. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
PLAB's Current ratio of 5.13 is fine compared to the rest of the industry. PLAB outperforms 78.18% of its industry peers.
A Quick Ratio of 4.76 indicates that PLAB has no problem at all paying its short term obligations.
The Quick ratio of PLAB (4.76) is better than 80.91% of its industry peers.
Industry RankSector Rank
Current Ratio 5.13
Quick Ratio 4.76
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

PLAB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.98%.
Measured over the past years, PLAB shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.90% on average per year.
The Revenue has decreased by -3.19% in the past year.
Measured over the past years, PLAB shows a quite strong growth in Revenue. The Revenue has been growing by 9.50% on average per year.
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%

3.2 Future

PLAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.07% yearly.
Based on estimates for the next years, PLAB will show a small growth in Revenue. The Revenue will grow by 0.93% on average per year.
EPS Next Y-11.62%
EPS Next 2Y1.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.04%
Revenue Next 2Y0.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.93, the valuation of PLAB can be described as reasonable.
Based on the Price/Earnings ratio, PLAB is valued cheaper than 97.27% of the companies in the same industry.
When comparing the Price/Earnings ratio of PLAB to the average of the S&P500 Index (27.03), we can say PLAB is valued rather cheaply.
A Price/Forward Earnings ratio of 10.91 indicates a reasonable valuation of PLAB.
Based on the Price/Forward Earnings ratio, PLAB is valued cheaply inside the industry as 96.36% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.63. PLAB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.93
Fwd PE 10.91
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

PLAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PLAB is cheaper than 99.09% of the companies in the same industry.
PLAB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PLAB is cheaper than 89.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.77
EV/EBITDA 2.49
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y1.07%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (8/25/2025, 8:00:01 PM)

After market: 22.07 0 (0%)

22.07

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-28 2025-05-28/bmo
Earnings (Next)08-27 2025-08-27/bmo
Inst Owners95.95%
Inst Owner Change-2.94%
Ins Owners4.12%
Ins Owner Change2.62%
Market Cap1.33B
Analysts84.44
Price Target31.84 (44.27%)
Short Float %5.45%
Short Ratio5.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.34%
Min EPS beat(2)-19.14%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-2.54%
Min EPS beat(4)-19.14%
Max EPS beat(4)11.24%
EPS beat(8)3
Avg EPS beat(8)-3.56%
EPS beat(12)5
Avg EPS beat(12)-0.54%
EPS beat(16)9
Avg EPS beat(16)5.15%
Revenue beat(2)0
Avg Revenue beat(2)-1.71%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-0.96%
Revenue beat(4)1
Avg Revenue beat(4)-2.84%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)1
Avg Revenue beat(8)-3.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.45%
Revenue beat(16)7
Avg Revenue beat(16)-0.66%
PT rev (1m)0%
PT rev (3m)-12.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.13%
Valuation
Industry RankSector Rank
PE 10.93
Fwd PE 10.91
P/S 1.55
P/FCF 14.77
P/OCF 5.24
P/B 1.21
P/tB 1.21
EV/EBITDA 2.49
EPS(TTM)2.02
EY9.15%
EPS(NY)2.02
Fwd EY9.16%
FCF(TTM)1.49
FCFY6.77%
OCF(TTM)4.21
OCFY19.09%
SpS14.24
BVpS18.3
TBVpS18.3
PEG (NY)N/A
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 10.9%
ROCE 14.05%
ROIC 10.42%
ROICexc 16.37%
ROICexgc 16.37%
OM 25.2%
PM (TTM) 14%
GM 36.29%
FCFM 10.49%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 200.08%
Cap/Sales 19.08%
Interest Coverage 250
Cash Conversion 85.14%
Profit Quality 74.94%
Current Ratio 5.13
Quick Ratio 4.76
Altman-Z 3.3
F-Score5
WACC11.66%
ROIC/WACC0.89
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.98%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-13.04%
EPS Next Y-11.62%
EPS Next 2Y1.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.77%
Revenue Next Year-3.04%
Revenue Next 2Y0.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.39%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year26.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.55%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-10.03%
OCF growth 3Y20.13%
OCF growth 5Y30.76%